J Hodge is an author at Pfizer (United States).
Publications per year
2014–2014
1
1
The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis
D L Boyle, K. Soma, J Hodge et al. · Annals of the Rheumatic Diseases · 2014 · 287 citations · Full text
Rows per page
1–1 of 1